V
Vista AI
Vista.ai leverages AI to provide clinicians with a simple, cost-effective, and stress-free method for conducting MRI studies
About Vista AI
Vista.ai, also known as HeartVista, is a medical technology company that specializes in artificial intelligence-driven software for the medical imaging sector. The company's main focus is on automating magnetic resonance imaging (MRI) exams to make them faster, more consistent, and accessible to a wider range of healthcare facilities and personnel.
The core product, Vista Cardiac, is an FDA-cleared software that automates and simplifies the image acquisition process for cardiac MRIs. This AI-powered platform is designed to be used by any clinician, regardless of their level of expertise, and can be implemented across any MRI scanner. The technology automatically prescribes the standard cardiac views, which helps to reduce the time it takes to perform an MRI and improves the overall quality and consistency of the images.
The company's business model is centered on providing software solutions to clinicians and healthcare providers. By automating the MRI process, Vista.ai aims to improve the efficiency and cost-effectiveness of diagnostic imaging, particularly in the field of cardiovascular disease. The company's target market includes hospitals, imaging centers, and other healthcare facilities that use MRI technology.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Redwood City, United States
- Employees
- 31
- Open positions
- None listed
- Dealroom signal
- 86.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, MRI, Radiology, Medical Imaging, Core AI, Spinout, Tech for Hospitals and Clinics, Tech for Medical Professionals, Generative AI
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2026 | $30M | $118M | Tampa General Hospital · Khosla Ventures · Intermountain Healthcare · Fox Chase Cancer Center | ↗ |
| SERIES A✓Equity / VC | Apr 2020 | $8.7M | $35M | Jeff Rothschild · Open Field Capital · Leslie Ventures · Khosla Ventures | ↗ |
Growth signals
Latest recorded traffic for Vista AI is 6.3K monthly website visits, down 8.7% over the last three months. Vista AI's team grew 6.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Khosla Ventures
National Institutes of Health
Series A9 investors entered at this stage
Jeff Rothschild
Open Field Capital- LVLeslie Ventures
Tampa General Hospital
Intermountain Healthcare
Fox Chase Cancer Center
University of Utah Hospital- CVCedars-Sinai Health Ventures
Bold Brain Ventures
Other known investors4 additional known investors
Stanford University
J-Ventures
Mike Thomas
Oded Hermoni
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vista AI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vista AI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.